There is widespread hope for curbing HIV after the United States Food and Drug Administration (FDA) approved an injectable ...

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...

The approval of Yeztugo is a momentous step in improving PrEP options available for people vulnerable to contracting ...

The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...

Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...

Merck on Thursday said the application covers the investigational, once-daily, oral two-drug regimen for adults with HIV-1 infection that is virologically suppressed on antiretroviral therapy. The ...